Sign In
Buy INVA
$21.70
+0.350 (+1.64%)
At Close: Jun 03, 2026
FDA Approves Glaxo’s First Homegrown Cancer Drug Since It Sold Cancer Pipeline
12:13pm, Thursday, 06'th Aug 2020
Belantamab is the first in a new generation of multiple myeloma therapies.
U.S. FDA approves GlaxoSmithKline's blood cancer drug
09:57am, Thursday, 06'th Aug 2020
The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's experimental treatment for a common form of blood cancer.
Tracking Kahn Brothers Portfolio - Q2 2020 Update
05:18am, Thursday, 06'th Aug 2020
Kahn Brothers’ 13F portfolio value increased from $547M to $592M this quarter. BP and Patterson-UTI were increased while reducing Hologic and Merck.
U.S. FDA approves GlaxoSmithKline's blood cancer drug
02:27am, Thursday, 06'th Aug 2020
The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's experimental treatment for a common form of blood cancer.
U.S. FDA approves GlaxoSmithKline's blood cancer drug
01:55am, Thursday, 06'th Aug 2020
The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's experimental treatment for a common form of blood cancer.
Pfizer Announces Times for Rescheduled Virtual Investor Day on September 14 and September 15, 2020
12:00am, Thursday, 06'th Aug 2020
Pfizer Inc. (NYSE: PFE) announced today that it will be holding its rescheduled Investor Day virtually over two days: Monday, September 14, 2020 from
Inhibrx Begins U.S. IPO Plan Rollout (Pending:INBX)
06:41pm, Wednesday, 05'th Aug 2020
Inhibrx has filed to raise $125 million in a U.S. IPO, although the final figure may vary.
Johnson & Johnson Signs $1 Billion U.S. Government Deal for Vaccine. Its Stock Is Rising.
02:20pm, Wednesday, 05'th Aug 2020
The agreement calls for the company to supply the U.S. 100 million doses if its vaccine is approved or wins emergency-use authorization from the FDA.
Alongside GlaxoSmithKline, I’d buy this FTSE share to make a million
11:24am, Wednesday, 05'th Aug 2020
When it comes to searching for shares to make a million, I reckon the healthcare sector is a well-stocked hunting ground.
Which coronavirus vaccine stock has the biggest potential to make me a millionaire?
09:29am, Wednesday, 05'th Aug 2020
Jonathan Smith outlines why GlaxoSmithKline is his top coronavirus vaccine stock right now, and also discusses Synairgen's potential.
Johnson & Johnson Clinches Coronavirus Vaccine Deal With US Government: $1B, 100M Doses
12:00am, Wednesday, 05'th Aug 2020
Johnson & Johnson (NYSE: JNJ) has become the latest large-cap biopharma company to strike a deal with the U.S. government to supply the coronavirus vaccine it has in...
Phase 3 Trials And More: Any COVID-19 Data Is Good Data, Even If It's Bad
07:59pm, Tuesday, 04'th Aug 2020
MRNA, PFE/BNTX, and AZN are leading the three vaccines in clinical phase 3 trials. Vaccines developed using different vectors have different advantages and disadvantages.
Flu shot makers plan to supply record numbers of vaccine doses amid Covid-19 pandemic
04:51pm, Tuesday, 04'th Aug 2020
Public health officials are making an even bigger push for flu vaccination this year to try to reduce hospitalizations from the disease amid the Covid-19 pandemic. Flu shot makers plan to supply recor
Did Hedge Funds Make The Right Call On Innoviva, Inc. (INVA)?
03:33pm, Tuesday, 04'th Aug 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
